ACELYRIN
Ken Lock is an accomplished executive with significant experience in commercial leadership within the biopharmaceutical industry. Currently serving as the Chief Commercial Officer at ACELYRIN, INC. and previously holding the same position at Arcutis Biotherapeutics, Inc., Ken has demonstrated expertise in driving product strategy and market performance. Earlier in the career, Ken was a Senior Product Manager for Enbrel at Pfizer, contributing to the management of a leading biologic therapy.
This person is not in any teams
This person is not in any offices
ACELYRIN
2 followers
ACELYRIN is a biopharma company that identifies, acquires, and accelerates the development and commercialization of life-changing therapies.